Athersys, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Athersys, Inc. (Athersys) is a biopharmaceutical company engaged in developing highly differentiated, potential best in class therapeutics for life-threatening diseases. The Company's lead programs are in the areas of obesity, cardiovascular disease, and bone marrow transplant support. The Company also develops pharmaceutical products for the treatment of certain conditions affecting the central nervous system. On August 31, 2007, Athersys, Inc. changed its name to ABT Holding Company, and BTHC VI, Inc. changed its name to Athersys, Inc. The company is headquartered in Cleveland, the United States.

The Athersys, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.